![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subc... Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts. Show more
SAN FRANCISCO and WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...
SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -7.02 | -16.1788430514 | 43.39 | 45.97 | 36.26 | 348992 | 41.69608249 | CS |
4 | -15.57 | -29.9768964189 | 51.94 | 52.07 | 36.26 | 374425 | 44.5746042 | CS |
12 | -27.83 | -43.3489096573 | 64.2 | 69.4 | 36.26 | 429193 | 52.09210721 | CS |
26 | 13.5 | 59.029296021 | 22.87 | 72.29 | 22.2 | 530459 | 51.45336815 | CS |
52 | 14.87 | 69.1627906977 | 21.5 | 72.29 | 14.19 | 438214 | 40.42227326 | CS |
156 | 14.87 | 69.1627906977 | 21.5 | 72.29 | 14.19 | 438214 | 40.42227326 | CS |
260 | 14.87 | 69.1627906977 | 21.5 | 72.29 | 14.19 | 438214 | 40.42227326 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions